LegiPlex
AI Workspace & Legislation Tracker
Creaet A Workspace
About
Sign Up
Login
Research Tools
Keyword Search
Bill Content
Videos & Transcripts
Capitol Directory (Beta)
US
Us Congress US
Legislatures
2025-2026 Regular Session
Senate
Bills
SB1096
US
Us Congress Senate Bill SB1096
Overview
Activity Timeline
Authors & Sponsors
Committee Assignments
Draft Versions & Texts
Latest Draft
Compare Versions
View All
Official Action Record
Meeting Schedule
Us Congress 2025-2026 Regular Session
Us Congress Senate Bill SB1096
Introduced
3/24/25
Refer
3/24/25
Report Pass
4/3/25
Caption
Preserve Access to Affordable Generics and Biosimilars Act
Latest SB1096 Activity
Companion Bills
No companion bills found.
Similar Bills
US SB5459
A bill to amend title XI of the Social Security Act to alter when biosimilar biological products are eligible for price negotiations under the Medicare program.
US SB1040
Drug Competition Enhancement Act
US HB3546
Prescription Drug Price Relief Act of 2025
US SB1414
Expedited Access to Biosimilars Act
US HB9184
Patient Access Act of 2024
US SB1095
Stop STALLING Act Stop Significant and Time-wasting Abuse Limiting Legitimate Innovation of New Generics Act
US HB8261
Preserving Telehealth, Hospital, and Ambulance Access Act
US SB142
Preserve Access to Affordable Generics and Biosimilars Act